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Lipid peroxide plays an important role in inflammatory lung diseases. 
Increased epithelial permeability produced by cigarette smoke is likely to be 
mediated though depletion of the Total Antioxidant Capacity .Oxidative 
stress has been recognized as a central feature of smoke induced chronic 
bronchitis. Imbalance between oxidants and Total Anioxidant Capacity is 
also an established fact in these patients. 60 patients with chronic bronchitis 
included in the study. Their base line clinical examination, malondialdehyde 
(MDA), nitric oxide, alpha tochopherol and Total Antioxidant Capacity were 
measured. 100 healthy non-smokers’ were served as controls. The mean 
malondialdehyde levels and nitric oxide in the patients at base line were 
higher than Controls (p<0.001). Plasma alpha-tocopherol and total 
antioxidant capacity were lower (p<0.001) in the patients compared to 
controls. The present study shows that initially the plasma lipid peroxide 
(MDA) levels were high and antioxidants. (alpha- tocopherol, total 
antioxidant capacity) were low in patients with chronic bronchitis. Our 
results suggest the presence of oxidative stress and decrease in total 
antioxidant capacity in chronic bronchitis. 
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1. INTRODUCTION 
Lung is the organ which is constantly exposed to many atmospheric pollutants such as cigarette 
smoke, ozone and nitrogen dioxide and is also at risk from oxidant injury by inhalation [1]. Inhaled ozone 
induces toxic processes that impair lung function. Lipid peroxide plays an important role in inflammatory 
lung diseases. Increased epithelial permeability produced by cigarette smoke is likely to be mediated though 
depletion Total Antioxidant Capacity [2]. Oxidant-antioxidant balance is essential for the normal lung 
function. Both an increased oxidants and or decreased antioxidants may reverse the physiologic oxidant-
antioxidants balance in favors of oxidants leading to lung injury. 
                    Chronic bronchitis is defined clinically that it is present in any patient who has persistant cough 
with sputum production for at least two consecutive years, in the absence of any other identifiable cause. In 
simple chronic bronchitis, patients have a productive cough but no physiologic evidence of airflow 
obstruction. Where some individual may demonstrate hyperreactive airways with intermittent bronchospasm 
and wheezing.  This condition is called chronic asthmatic bronchitis some patients, especially heavy smokers, 
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develop chronic airflow obstruction usually with evidence of associated emphysema and are classified as 
obstructive chronic bronchitis. 
       The earliest feature of chronic bronchitis is hyper secretion of mucus in the large airways associated 
with hypertrophy of the submucosal glands in the trachea and bronchi.  As chronic bronchitis persist there is 
also marked increase in goblet cells of small airways-small bronchi and bronchioles-leading to excessive 
mucus production that contributes to airway obstruction [3].                                                                   
                 Now a days attempt towards oxidative stress status is continuing. The study of antioxidant capacity 
in lung disease patients opens a promising field in prevention of oxidative stress related complications in 
these patients. The aims and objectives are: to explore the existence of possible peroxidative damage in lung 
disease patients by estimating the level of serum malondialdehyde as an index of lipid peroxide; to estimate 
nitric oxide as a marker of oxidative stress; to study possible alteration in Total antioxidant Status in lung 
disease patients by estimating the total antioxidant capacity; and to study non enzymatic antioxidant  
vitamin E.  
 
 
2.  MATERIALS AND METHODS 
The present study was conducted in the department of Biochemistry Dr. Vikhe Patil Medical 
College and Hospital Ahmednagar. This study included 60 clinically stable COPD Patients in the age group 
of 35-60 years, 100 healthy controls who were diagnosed by physicians on the basis of detailed clinical 
histry, clinical examination and relevant biochemical examinations.  
Hypertension, malignancy, overt cardiac failure recent surgery, severs endocrine, hepatic or renal 
diseases and lung disorders other than COPD were excluded from the present study. Informed consent was 
obtained from each patient in the study. The study was cleared by institutional ethics committee. 10 ml blood 
was collected from each patient. Serum was separated by centrifugation at 3000 rpm for 10 minutes at room 
temperature.  Following parameters were carried out on the samples on the same day of collection: 
1. The level of serum total lipid peroxide in terms of Malondiadehyde (MDA) was determined by Kei 
Satoh method [4]. 
2. Serum Nitric oxide (NO.) as nitrite was estimated by Najwa Cortas and Nabil Wakid method [5] 
3. Serum Vitamin ‘E’ (α-Tocopherol) was estimated by the method of Baker and Frank [6] 
4. 4-Total antioxidant capacity in plasma (TAC) was assayed by FRAP analysis [7] 
 
 
3.  RESULTS AND DISCUSSIONS 
Table 1 Illustrate the levels of MDA, NO*, Vitamin E and TAC in the healthy controls and chronic 
bronchitis patients.  
 
 
Table 1. Levels of MDA, NO*, Vitamin E and TAC in the healthy controls and chronic bronchitis patients 
Test Healthy Controls n=100 Chronic Bronchitis patients n=60 
Sr. MDA (umol/L) 1.66±0.289 4.61±2.7* 
Sr. No* (umol/L) 33.15±6.13 33.58±12* 
Sr. Vit E (mg/dl) 0.927±0.12 0.32±0.09* 
Sr.TAC (umol/L)                1253.12±170.22 354.43±88* 
n = number of cases 
All values are expressed in mean ± SD 
* = Significant when compared with control group 
 
                                                                                                                                                  
It was carried out using students unpaired’ test. Probability values 0.05 were considered as significant. Also 
data were expressed in mean ± SD form. Table 1, results of the present study showed significant high levels 
(p< 0.001)  of oxidants serum lipid peroxide (MDA) and serum nitric oxide (NO*) were observed as 
compared to healthy controls. The mean plasma levels of Vit. E (P<0.001) and total antioxidant capacity 
(TAC) was lower than controls. 
                Lung cells, in particular alveolar epithelial type II cells, are susceptible to the injurious effects of 
oxidants. Lungs are continuously exposed to oxidants, either generated endogenously by metabolic reactions 
or exogenously, such as air pollutants or cigarette smoke and since Cigarette smoking, another environmental 
hazard, also delivers oxidants and free radicals to the lungs. Cigarette smoke contains many oxidants and free 
radicals, both in the gas and the tar phase and causes sequestration of neutrophils into the pulmonary 
microcirculation and accumulation of macrophages in respiratory bronchioles. Once recruited, these cells 
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become activated and generate ROS. ROS, which may also be released by lung epithelial cells, may also 
stimulate inflammatory cells directly, thereby amplifying lung inflammatory and oxidant events. There by 
increases the MDA significantly in chronic bronchitis patients [8]. 
              In the respiratory tract, NO˙ is generated enzymatically by all three distinct isoforms of NO˙ 
synthase i.e. NOS-1, NOS-2 and NOS-3. Of these three forms NOS-2 activity is primarily regulated 
transcriptionally and is commonly induced by bacterial products and pro-inflammatory cytokines.  
Inflammatory diseases of the respiratory tract such as chronic bronchitis is commonly characterized by an 
increased expression of NOS-2 within respiratory epithelial and inflammatory immune cells, and markedly 
elevated local production of NO˙ in the patients with lung diseases [9]. 
Vitamin E is the most important lipophilic antioxidant in humans in this study we observed the 
reduced vitamin E level in lung disease patients could be due partly to its overconsumption as an antioxidant 
subsequent to increased production of free radicals by cigarette smoke and inflammatory reaction.  
The total antioxidative potential of the plasma reflects the ability of an individual to resist the 
oxidative stress. Ferric reducing ability of plasma (FRAP) evaluates plasma total antioxidant capacity due to 
known and unknown antioxidants in the plasma [10]. Therefore in the present study   significant reduction 
observed in total ferric reducing ability of plasma may be due to increased free radical activity either because 
of inflammation or complications that results in imbalance between antioxidant capacity and proxidant 
affecting lung function. Extensively amplified oxidant burden and declined individual antioxidant levels 
might be responsible for the observed significant fall in total antioxidant capacity of patients with lung 
disease. 
 
 
4.  CONCLUSION  
              Thus evaluating oxidative stress in lung disease patients by measuring lipid peroxidation and 
antioxidant status can lead to better understanding of free radical mediated damage in chronic bronchitis 
patients.  An inequity between oxidative stress and antioxidative capacity has been proposed to play an 
important role in the development and progression of chronic bronchitis and it is related to the severity of 
disease. 
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